Showing results (201-210 of 231) with videos related to
Sort By:
Pageof 24
ISRN Oncology|October 10, 2013
UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-AnalysisMarce-Amara Kpoghomou, Joella Eldie Soatiana, Fatch W Kalembo, et al.ISRN Oncology|October 11, 2013
Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?V Patil, V Noronha, A Joshi, et al.ISRN Oncology|July 11, 2013
Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and developmentGaetano RomanoISRN Oncology|July 11, 2013
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapyEdwin BremerISRN Oncology|July 12, 2013
Changes among US Cancer Survivors: Comparing Demographic, Diagnostic, and Health Care Findings from the 1992 and 2010 National Health Interview SurveysNatasha D Buchanan, Jessica B King, Juan L Rodriguez, et al.ISRN Oncology|May 22, 2013
Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?Carsten Nieder, Oddvar Spanne, Ellinor Haukland, et al.ISRN Oncology|May 22, 2013
Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer WomenAyodeji O J Agboola, Adekumbiola A F Banjo, Charles C Anunobi, et al.ISRN Oncology|May 22, 2013
Proteoglycan expression in normal human prostate tissue and prostate cancerAnastasia V Suhovskih, Lyudmila A Mostovich, Igor S Kunin, et al.ISRN Oncology|May 22, 2013
Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in JapanMasahiro Yokoyama, Yasuhito Terui, Kengo Takeuchi, et al.ISRN Oncology|February 23, 2013
Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National PopulationEribeth K Penaranda, Navkiran Shokar, Melchor OrtizPageof 24